Leukotriene B4 (LTB4) is a potent neutrophil activator and chemotaxin that is present in increased concentrations in the colonic tissue and rectal dialysates of acute ulcerative colitis patients. Cottontop tamarins (CTTs) with confirmed active colitis were treated with the second generation LTB4 receptor antagonist, 
Abstract
Leukotriene B4 (LTB4) is a potent neutrophil activator and chemotaxin that is present in increased concentrations in the colonic tissue and rectal dialysates of acute ulcerative colitis patients. Cottontop tamarins (CTTs) with confirmed active colitis were treated with the second generation LTB4 receptor antagonist, ( 20 [3] [4] [5] [6] [7] (0.8) ng/ml (p<0.001) and 2.3 (0.5) ng/ml (p<0.01) at days 28 and 56, respectively. On the other hand, mucosal protective PGE values remained constant or slightly increased during SC-53228 treatment (pre: 6-9 (2.2) ng/ml; day 28: 6.7 (1.4) ng/ml; day 56: 9.9 (1.6) nglml). Furthermore, assessment of a panel of 35 clinical chemistry and haematology parameters throughout the treatment showed there were no significant untoward effects of drug treatment. Six CCTs finished the eight week treatment and five ofsix gained weight (ranging from 27-121 grams each) while one CTT lost weight (50 g). Stool 
Assessment of disease activity
Symptoms -stool consistency was followed throughout the study and qualitatively graded on a scale from 1-4 (1 =firm: formed stool; 2=loose: semi-formed stool that did not hold its shape after being passed but was not watery; 3=puddly: semi-liquid stool that lost its shape quickly while being passed but could not be described as a solution or suspension; 4=diar-rhoea: liquid stood that was watery with no form at all and resembled a dilute suspension).
Endoscopy-the colonoscopy procedure for visualisation and obtaining colonic mucosal samples is described in detail elsewhere.7 Briefly, fasted animals were anaesthetised with ketamine hydrochloride (20-25 mg/lkg bw) plus butorphanol tartrate (0O 1 5-0.25 mg/kg bw) and examined visually. Two mucosal biopsy specimens were taken at 5, 10, and 15 cm from the anus and fixed in buffered formalin. Any abnormality was described and sampled. Histological tissues were stained with PAS and evaluated for colitic activity.
Disease activity index -histological evaluation of colonic biopsy specimens was performed in a blinded fashion at several laboratories.'7 Mucosal histological score was graded on a scale of 0-5 (0=chronic: no evidence of increased neutrophils (PMN) in lamina propria, crypt epithelium or in the crypt lumen along with increased numbers of chronic inflammatory cells such as plasma cells, lymphocytes, and histocytes; 1=active mild: increase of a few PMNs in lamina propria; 3=active moderate: PMNs increased in at least two areas (lamina propria and epithelium) with some crypt abscesses; 5=active severe: PMNs heavily infiltrated through mucosa and lamina propria with abscesses in most crypts).
Subject well being -animal body weights were obtained biweekly and chemistry and haematological screens were performed before the experiment and 28 and 56 days after.
Drug treatment SC-53228 was formulated as a sonicated suspension (5 mg/ml) in 0.50/o methylcellulose. Twenty mg/kg bw was given by gavage twice daily at 0800 and 1600.
Rectal dialysate studies Rectal dialysis bags were placed in the rectum and descending colons for 1'/4 hours under ketamine anaesthesia as previously described. '8 The dialysate solution was composed of sodium chloride, potassium bicarbonate, and fatty acid free albumin adjusted to pH 7.1 with NaOH. Upon removal of the bag, the dialysate was immediately frozen (-70°C) and subsequently analysed for content of lipid mediators of inflammation. (Table) . (0.5) ng/ml (p<0-001) after 56 days of SC-53228 treatment (Fig 2A) . These concentrations rose (p<0 05 v day 56) to 8.1 (0.7) ngfml by day 240 but were still lower (p<0.001) than pretreatment values. In addition, PGE concentrations rose slightly, but non-significantly, from pretreatment values (6-92 (2.2) ng/ml) and remained slightly higher at day 240 (9-01 (2.6) ng/ml) (Fig 2B) .
Measurement of lipid mediators
Colonic biopsy inflammatory index dropped in all animals by day 56 of treatment (Fig 3) . In addition, at day 240, four of five remaining animals maintained remission while one of five worsened. Pretreatment histological examination was characterised by crypt abscesses, granulocyte infiltration, and mucus depletion, and a diffuse, chronic inflammatory cell infiltrate in the mucosa (Fig 4A) . After 56 days of treatment colonic tissue obtained from the same animal, at the same position (10 cm from the anus), showed a dramatic reduction in inflammatory cells along with increased mucus production (Fig 4B) . Figure 5 shows the histological changes in the colonic mucosa 
